Belharra: The Birth of a Biotech Podcast

In this episode, we hear from three of our outstanding leaders at Belharra, and veteran drug hunters, Yvonne Schmidt, our director of chemistry; Jessica Alexander, our head of program management; and Olesya Ulanovskaya, our senior director of biology. We discuss not only the critical work they each do at Belharra, but also their perspectives and experiences as women in science and biotech. For any girls or young women out there who...

Hear from one of our core team members, Mike Lazear, who designs and implements the complex data infrastructure that enables our innovative chemoproteomic screening platform. This episode lets listeners get under the hood of an incredibly powerful and innovative data processing tool, explores the possibilities of integrating machine learning and artificial intelligence, and sheds light on the power of data to make a true impact in ...

Our special guests on today’s episode include Sherry Niessen, Belharra’s head of platform and proteomics; Sean Buchanan, our head of biology; and Justin Ernst, our head of chemistry. We learn about the individual journeys to science careers and, ultimately to Belharra, that each of these talented scientific leaders took. We talk about how their functional teams work together to advance our mission to develop game-changing medicines...

In this episode, we speak with Gary O'Neill, Chief Scientific Officer at Belharra, about our next-generation chemoproteomics platform, which has the potential to open up the entire proteome – for the first time – to small molecule screening which could lead to many undruggable proteins becoming druggable. Most importantly, we talk about the immense positive impact we believe this science and our platform could have for individuals ...

We continue our story with a conversation with Tom Woiwode from Versant Ventures and Jeremy Caldwell from Red Tree Venture Capital and formerly of Versant Ventures and Inception Therapeutics – two of the individuals who played a key role in turning the breakthrough scientific ideas that were bubbling up from Chris Parker and John Teijaro at The Scripps Research Institute into a company. Tom is managing director of Versant Ventures ...

In our first episode, we’ll hear from the extraordinary scientists Chris Parker and John Teijaro, who are two of the co-founders of Belharra Therapeutics. Chris and John tell the stories of their respective childhoods growing up in the Rust Belt, their unique paths to getting their Ph.D.s, their serendipitous post-doc meet-up at The Scripps Research Institute, and how their scientific curiosity and their collaboration with the othe...

Ever wondered how a brilliant scientific idea is transformed from lab findings to a new biotech start-up…and eventually to new medicines that can impact millions of patients’ lives? In this podcast, we peel back the covers on the early stages of this process through telling the story of Belharra Therapeutics, a promising chemoproteomics company seeking to lead a new wave of drug discovery. Belharra launched just one year ago from a...